Related Experiment Video
Updated: Mar 20, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma
Hongsheng Yue1, Jie Zhu1, Shugang Xie2
1Department of Neurosurgery, Ji'nan Central Hospital Affiliated to Shandong University, Ji'nan 250013, PR China.
Background:
Growing number of long noncoding RNAs (lncRNAs) are emerging as new modulators in cancer origination and progression. A lncRNA, mediator of DNA damage checkpoint protein 1antisense RNA (MDC1-AS), with unknown function, is the antisense transcript of tumor suppressor MDC1.
Method:
In this study, we investigated the expression pattern and functional role of lncRNA MDC1-AS in glioma by using real time PCR and gain-/loss-of-function studies.
Result:
The results showed that the expression levels of lncRNA MDC1-AS and MDC1 were significantly downregulated in glioma tissues compared with normal brain tissues, and in glioma cell lines U87MG, U251 and HEB. Overexpression of MDC1-AS resulted in significant inhibition of cell proliferation and cell cycle in U87MG and U251. We also found that MDC1-AS expression was positively correlated with MDC1 expression. In addition, the inhibitory role of MDC1-AS was remarkably diminished when MDC1 was knockdown.
Conclusion:
Together, the results suggest that MDC1-AS is a novel tumor suppressor through up-regulation of its antisense tumor-suppressing gene MDC1 in glioma and leads us to propose that MDC1-AS may serve as a potential biomarker and therapeutic target for glioma.
Insights
Mediator of DNA damage checkpoint protein 1 antisense RNA (MDC1-AS) acts as a tumor suppressor in glioma. Its downregulation correlates with glioma progression, suggesting MDC1-AS as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) are increasingly recognized as key regulators in cancer development and progression.
- Mediator of DNA damage checkpoint protein 1 antisense RNA (MDC1-AS), a lncRNA with an uncharacterized function, is the antisense transcript of the tumor suppressor gene MDC1.
Purpose of the Study:
- To investigate the expression patterns and functional significance of lncRNA MDC1-AS in glioma.
- To elucidate the role of MDC1-AS in glioma cell proliferation and cell cycle regulation.
Main Methods:
- Real-time PCR was employed to determine expression levels of MDC1-AS and MDC1 in glioma tissues and cell lines.
- Gain- and loss-of-function studies were conducted to assess the impact of MDC1-AS on glioma cell behavior.
Main Results:
- lncRNA MDC1-AS and MDC1 expression were significantly reduced in glioma tissues and cell lines compared to normal controls.
- Overexpression of MDC1-AS inhibited glioma cell proliferation and cell cycle progression.
- MDC1-AS expression positively correlated with MDC1 expression, and its inhibitory effect was dependent on MDC1 levels.
Conclusions:
- MDC1-AS functions as a novel tumor suppressor in glioma by upregulating its antisense tumor-suppressing gene, MDC1.
- MDC1-AS presents a promising potential biomarker and therapeutic target for glioma treatment.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Experimental RNAi
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs

